Recently, Yun and his colleagues reported that MAGI3 by interaction with LPA2 and phospholipase C-β3, could decrease the tumorigenic capacity via inhibition of LPA-induced activation of NF-κB and JNK in colon cancer cells [42]. The gene discussed is NFKB1; the disease is colonic neoplasm.